We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current FNAM market cap is 2.99M. The company's latest EPS is USD -0.3378 and P/E is -1.33.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 115k | 123k | 13k | 0 | 0 |
| Operating Income | -837k | -775k | -2.88M | -2.88M | -2.01M |
| Net Income | -1.34M | -1.06M | -2M | -3.08M | -2.25M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.39M | 4.24M | 3.99M | 2.93M | 2.35M |
| Total Liabilities | 955k | 1.01M | 2.25M | 3.76M | 3.92M |
| Total Equity | 404k | -334k | -1.83M | -4.4M | -5.59M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -749k | -626k | -2.3M | -1.58M | -641k |
| Investing | N/A | N/A | 148k | N/A | N/A |
| Financing | N/A | 540k | 2.32M | 1.58M | 1M |
| Market Cap | 2.99M |
| Price to Earnings Ratio | -1.33 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.19 |
| Price to Book Ratio | -1.91 |
| Dividend Yield | - |
| Shares Outstanding | 6.66M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -32.58% |
| 52 Week High | 0.70 |
| 52 Week Low | 0.45 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Evolutionary Genomics Inc Common Stock (CE) |
| Address |
3773 howard hughes pkwy las vegas, nevada 89169 |
| Website | https://www.evolgen.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
